Neurological Disorders Drugs Market Size, Share, Analysis, Industry Report and Forecast 2021-2027
The global neurological disorders drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). Neurological disorders are characterized by dysfunction in any part of the brain or nervous system, which causes damage or injury. For the treatment of neurological illnesses, a variety of neurological medications such as antipsychotics, antiepileptics, anticholinergics, and analgesics are available on the market.
The growth of neurological
disorders drug market is expected to witness due to significant investment in
R&D. In September 2020, A team led by Rutgers has developed a smart
medicine delivery device that supports cure spinal cord injuries and other
neurological illnesses by reducing inflammation in injured neural regions.
According to a study published in the journal Advanced Materials, the
technology, which uses incredibly thin biomaterials implanted in the body, also
protects nerve fibres (axons) that connect nerve cells in wounded brain
tissues. Ultrathin nanomaterials, sugar polymers, and neuronal proteins make up
the team's unique medication delivery method. The mechanism, which releases an
anti-inflammatory chemical (methylprednisolone), can support promote tissue repair
and recovery after a brain injury by creating a favourable microenvironment. As
inflammation is linked to a range of disorders such as CVD, osteoarthritis,
diabetes, and cancer, the researchers believes the new approach could pave the
way for treating not only central nervous system injuries, however, also other
ailments.
To Request a Sample of our Report on Neurological
Disorders Drugs Market: https://www.omrglobal.com/request-sample/neurological-disorders-drugs-market
The key companies operating in
the industry are highly inclined towards the adoption of different growth
strategies including capacity expansion, partnerships, mergers and
acquisitions, geographical expansion, new product launch, FDA Approval and
product innovation to remain competitive in the marketplace. For instance,
Aduhelm (aducanumab) was approved by the US Food and Drug Administration in
June 2021 for the treatment of Alzheimer's disease, a severe condition that
affects 6.2 million Americans. Aduhelm was approved through the accelerated
approval pathway, which is reserved for drugs that give a significant
therapeutic advantage over existing treatments for serious or life-threatening
illnesses. With a mandatory post-approval trial to verify that the medicine
achieves the projected clinical benefit, accelerated approval can be based on
the drug's effect on a surrogate endpoint that is fairly likely to predict a
therapeutic benefit to patients.
Market Coverage
•
The market number available for – 2020-2027
•
Base year- 2020
•
Forecast period- 2021-2027
Segment Covered-
•
By Disease
•
By Distribution Channel
Regions covered-
•
North America
•
Europe
•
Asia-Pacific
•
Rest of the World
Competitive Landscape: Pfizer Inc., Teva
Pharmaceutical Industries Ltd., and Sanofi S.A., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Neurological Disorders Drugs Market is Available @ https://www.omrglobal.com/industry-reports/neurological-disorders-drugs-market
Global Neurological Disorders Market Report by Segment
By Disease
•
Epilepsy
•
Parkinson's disease
•
Alzheimer's disease
•
Others
By Distribution Channel
•
Hospital Pharmacies
•
Retail Pharmacies
•
Online Pharmacies
Global Neurological Disorders Market
Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment